Form 4: Abeona Therapeutics Director Mark Alvino Reports Acquisition and Disposal of Common Stock

Director Mark Alvino reports acquiring 23,611 shares of Abeona Therapeutics common stock and disposing of an unspecified amount on July 8, 2024.

Summary

• On July 8, 2024, Mark Alvino, a director of Abeona Therapeutics Inc., reported a transaction involving the company's common stock.
• Alvino acquired 23,611 shares of common stock.
• The acquisition price was $0.00.
• Alvino also disposed of an unspecified amount of common stock.
• Following the reported transactions, Alvino beneficially owns 60,537 shares of Abeona Therapeutics common stock.
• The restricted stock acquired will vest on July 8, 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document reports both acquisition and disposal of shares by a director. Further context is needed to determine the overall impact.

Positives

• The acquisition of shares by a director could be interpreted as a positive signal about the company's prospects.

Negatives

• The disposal of an unspecified amount of shares by the same director on the same day could be interpreted as a negative signal.

Risks

• The document does not provide enough information to assess the reasons behind the stock disposal, which could be a risk factor.

Industry Context

This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It's important to monitor such filings in conjunction with other news and financial data to form a comprehensive view of the company's health and prospects.

Stakeholder Impact

• Shareholders may be interested in the trading activity of company directors as an indicator of confidence in the company's future.

Key Dates